U.S. Trade Distributors Stock News

Why First Busey’s latest earnings and buyback matter for investors First Busey (BUSE) has drawn fresh attention after second quarter and year to date results showed much higher net income and earnings per share, alongside the completion of a multi year share repurchase program. See our latest analysis for First Busey. At a share price of $30.86, First Busey has delivered a 15.97% 90 day share price return and a 45.10% 1 year total shareholder return, which indicates that recent earnings and...

Eton Pharmaceuticals (ETON) has filed a Prior Approval Supplement with the U.S. Food and Drug Administration to expand KHINDIVI’s label to younger pediatric patients, following bioequivalence data versus ALKINDI SPRINKLE hydrocortisone granules. See our latest analysis for Eton Pharmaceuticals. The KHINDIVI label expansion filing comes after a very strong run in Eton Pharmaceuticals’ stock, with a 30 day share price return of 26.73%, a 90 day share price return of 60.62% and a year to date...

In late July 2026, Myriad Genetics reported second-quarter results showing revenue of US$190.7 million versus US$213.1 million a year earlier, alongside a reduced full-year 2026 revenue outlook of US$770 million to US$790 million due to weaker Prenatal Health test volumes and more cautious assumptions for revenue per test. Despite the revenue decline, the company’s net loss narrowed sharply to US$43.2 million from a very large loss a year ago, highlighting significant cost or non-operational...

Q2 results and capital return actions in focus for Hyatt Hotels stock Hyatt Hotels (H) has drawn investor attention after its second quarter 2026 earnings, the Board-approved third quarter dividend, an updated full-year net income outlook, and progress on a multi-year share repurchase program. See our latest analysis for Hyatt Hotels. Despite Q2 earnings, guidance and capital returns in focus, Hyatt Hotels shares have pulled back recently, with the 30 day share price return down 8.8% and the...

In late July 2026, Core Scientific, Inc. reported Q2 2026 revenue of US$164.2 million alongside a net loss of US$1.16 billion, and announced a large‑scale AI infrastructure partnership with Advanced Micro Devices, Inc. involving up to 2.5 gigawatts of potential data center capacity and related stock warrants for Advanced Micro Devices, Inc. Core Scientific, Inc. also added veteran technology executive Mark W. Adams to its expanded seven‑member Board of Directors, strengthening oversight as...

Tariffs on Canadian imports and higher taxes on generic drugs are shaking up expectations for costs and pricing across healthcare. For U.S. specialty pharmaceutical manufacturers, this mix of pressure and opportunity can be important. Some companies may face higher input costs. Others with more domestic production may see a relative edge if imported generics become more expensive. This article explains how the new trade measures could matter for your portfolio and discusses 3 U.S. specialty...

Last week saw the newest quarterly earnings release from BigBear.ai Holdings, Inc. ( NYSE:BBAI ), an important...

With the Federal Reserve sounding more hawkish and futures markets pricing a 72% chance of a rate hike by September, many investors are rethinking where they want their money to work. Higher expected yields on safer assets can change the appeal of riskier choices, including Bitcoin and some growth stocks. In this environment, large U.S. value stocks with lower volatility and modest P/E and P/B ratios can look interesting to some investors. This article walks through 3 U.S. large cap value...

Loma Negra Compañía Industrial Argentina Sociedad Anónima (LOMA) came into focus after a recent share price move, with the stock closing at $11.48. Investors may now reassess its longer term return profile. See our latest analysis for Loma Negra Compañía Industrial Argentina Sociedad Anónima. The recent move to a share price of $11.48 comes after a mixed run, with the 90 day share price return of 8.20% set against a year to date decline of 10.87%. The 5 year total shareholder return of...

RBC Bearings Incorporated has reported its fiscal first-quarter 2027 results, with net sales rising to US$519.5 million and net income to US$101.5 million, and has issued second-quarter guidance calling for net sales between US$505.0 million and US$515.0 million, implying double-digit year-over-year growth. The combination of strong Aerospace & Defense demand, broad-based Industrial segment growth, and guidance that points to continued operational momentum highlights how current end-market...

California Water Service Group (CWT) reported second quarter results that attracted investor attention, with higher sales, net income, and earnings per share compared with the same period a year earlier. See our latest analysis for California Water Service Group. At a share price of $50.11, California Water Service Group has seen a 90 day share price return of 18.3% and a year to date share price return of 16.7%, while the 1 year total shareholder return of 10.8% contrasts with a 5 year total...

It's been a good week for The Baldwin Insurance Group, Inc. ( NASDAQ:BWIN ) shareholders, because the company has just...

Check Point Software Technologies Ltd. ( NASDAQ:CHKP ) shareholders are probably feeling a little disappointed, since...

Tariffs on Canadian dairy, alcohol, and autos are reshaping expectations for cross border trade, and that puts the spotlight on U.S. Domestic Manufacturing stocks with direct or indirect exposure to this news. The new 50% tariffs and the risk of retaliation could shift where goods are produced, how supply chains are structured, and which companies gain or lose pricing power. This article looks at three stocks from the U.S. Domestic Manufacturing screener that appear to be positively exposed...

In July 2026, Las Vegas Sands Corp. reported second-quarter 2026 results showing slightly lower quarterly sales and net income year on year, alongside stronger six-month revenue and earnings, while also affirming a quarterly dividend of US$0.30 per share. At the same time, the company completed a long-running US$8.07 billion buyback program and increased its remaining repurchase authorization to US$6.00 billion through 2029, highlighting an ongoing commitment to returning capital to...

Community Financial System (CBU) has drawn fresh investor attention after releasing second quarter 2026 results, reporting net income of US$61.33 million, lower net charge offs, updated buyback activity, and a new quarterly dividend declaration. See our latest analysis for Community Financial System. Community Financial System's recent earnings, buyback activity, and dividend increase come against a share price of US$64.81 that is modestly lower over the past month yet still ahead year to...

In July 2026, Live Oak Bancshares, Inc. reported second-quarter 2026 results showing net interest income of US$125.34 million and net income of US$36.8 million, both higher than the same period a year earlier, with basic earnings per share from continuing operations rising to US$0.75. Alongside this earnings strength, the bank’s net charge-offs fell to US$24,162,000 from US$31,445,000 a year before, highlighting an improvement in credit costs that could be particularly important for a...

XTransfer, a leading B2B cross-border trade payment platform, has been named to CNBC's 2026 list of the World's Top Fintech Companies in the Payments Segment, highlighting its growing impact in the digital payments landscape. This recognition underscores the company's commitment to providing secure and efficient cross-border payment solutions for SMEs, thereby addressing the complexities of international financial operations. XTransfer's inclusion in this prestigious list, compiled with...

The latest Federal Reserve meeting kept interest rates on hold but still triggered the Dow’s worst single-session drop in over a year and exposed rare internal division at the FOMC. With inflation at 4.2% and pressure building on long-term Treasury yields, many investors are reassessing how much risk they want to carry in rate sensitive areas of the market. This article looks at three dividend paying stocks from our Defensive Dividend Stocks screener that appear closely tied to these cross...

Euronet Worldwide earnings and buyback activity in focus Euronet Worldwide (EEFT) reported second quarter 2026 results that combined higher sales with lower profitability, while also updating investors on progress under its multi year share repurchase program. Sales for the quarter reached US$1,108.4 million compared with US$1,074.3 million a year earlier. Net income was US$77.4 million versus US$97.6 million, with diluted earnings per share from continuing operations at US$1.71 compared with...

The latest merger speculation swirling around AstraZeneca and Bristol Myers Squibb has pushed large cap pharma stocks back into the spotlight. Sharp price moves, including AstraZeneca’s intraday fall of up to 7% and a 6% premarket jump for Bristol Myers, show how quickly sentiment can shift when potential mega deals hit the headlines. For investors, this kind of disruption can surface both opportunities and risks. This article looks at 3 stocks from a Healthcare screener that are exposed to...

Autohome (NYSE:ATHM) has announced a new share repurchase program of up to US$400 million. The program has been authorized by its Board and is set to run for 12 months, funded entirely from existing cash reserves. See our latest analysis for Autohome. The buyback news lands after a strong short term share price run for Autohome, with a 7 day share price return of 10.0% and a 30 day return of 21.63% helping to lift the 90 day share price return to 24.84%. However, the 1 year total shareholder...

Cullinan Therapeutics reported that it previously received positive feedback from the U.S. FDA following an End-of-Phase 1 meeting for CLN-049, clearing the way for a potentially registrational Phase 2 trial in relapsed/refractory acute myeloid leukemia and additional combination studies in previously untreated patients. The FDA’s alignment on a seamless Phase 2 design and CLN-049’s Fast Track and Orphan Drug designations together underscore the program’s regulatory momentum in a...

The United States market remained flat over the last week but has shown an impressive 18% rise over the past 12 months, with earnings forecasted to grow by 16% annually. In this context, identifying stocks that are potentially undervalued can be crucial for investors seeking opportunities in a dynamic market environment.